Correlation between serum magnesium and malnutrition-inflammation-atherosclerosis syndrome in maintenance hemodialysis patients

Chinese Journal of Clinical Nutrition

Volumn 22, Issue 6, 2014, Pages 348-353

  Yu, Ling ^a   Li, Han ^a   Wang, Shixiang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Maintenance hemodialysis; Malnutrition inflammation atherosclerosis syndrome; Related factor; Serum magnesium

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; HIGH SENSITIVITY C REACTIVE PROTEIN; MAGNESIUM; POTASSIUM; UNCLASSIFIED DRUG; URIC ACID;

ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; ASSOCIATION; ATHEROSCLEROSIS; CHRONIC INFLAMMATION; CREATININE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAGNESIUM BLOOD LEVEL; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALNUTRITION; MALNUTRITION INFLAMMATION ATHEROSCLEROSIS SYNDROME; MID ARM MUSCLE CIRCUMFERENCE; MUSCULOSKELETAL SYSTEM PARAMETERS; NUTRITIONAL STATUS; POTASSIUM BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 84921838826     PISSN: 1674635X     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1674-635X.2014.06.006     Document Type: Article

References (22)

1. Stenvinkel P, Heimbürger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure [J]. Kidney Int, 1999, 55 (5): 1899-1911.
2. Turgut F, Kanbay M, Metin M, et al. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis [J]. Int Urol Nephrol, 2008, 40 (4): 1075-1082.
3. Kalantar-Zadeh K, Kleiner M, Dunne E, et al. A modified quantitative subjective global assessment of nutrition for dialysis patients [J]. Nephrol Dial Transplant, 1999, 14 (7): 1732-1738.
4. Mountokalakis TD. Magnesium metabolism in chronic renal failure [J]. Magnes Res, 1990, 3 (2): 121-127.
5. Tatsumi H, Masuda Y, Imaizumi H, et al. A case of cardiopulmonary arrest caused by laxatives-induced hypermagnesemia in a patient with anorexia nervosa and chronic renal failure [J]. J Anesth, 2011, 25 (6): 935-938.
6. Kanbay M, Yilmaz MI, Apetrii M, et al. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients [J]. Am J Nephrol, 2012, 36 (3): 228-237.
7. Campbell KL, Ash S, Bauer JD, et al. Evaluation of nutrition assessment tools compared with body cell mass for the assessment of malnutrition in chronic kidney disease [J]. J Ren Nutr, 2007, 17 (3): 189-195.
8. Almoznino-Sarafian D, Berman S, Mor A, et al. Magnesium and C-reactive protein in heart failure: an anti-inflammatory effect of magnesium administration? [J]. Eur J Nutr, 2007, 46 (4): 230-237.
9. Moslehi N, Vafa M, Rahimi-Foroushani A, et al. Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women [J]. J Res Med Sci, 2012, 17 (7): 607-614.
10. Guerrero-Romero F, Bermudez-Peña C, Rodríguez-Morán M. Severe hypomagnesemia and low-grade inflammation in metabolic syndrome [J]. Magnes Res, 2011, 24 (2): 45-53.
11. Kim DJ, Xun P, Liu K, et al. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes [J]. Diabetes Care, 2010, 33 (12): 2604-2610.
12. Chacko SA, Song Y, Nathan L, et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women [J]. Diabetes Care, 2010, 33 (2): 304-310.
13. Fein P, Suda V, Borawsky C, et al. Relationship of serum magnesium to body composition and inflammation in peritoneal dialysis patients [J]. Adv Perit Dial, 2010, 26: 112-115.
14. Maier JA, Malpuech-Brugère C, Zimowska W, et al. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis [J]. Biochim Biophys Acta, 2004, 1689 (1): 13-21.
15. Mazur A, Maier JA, Rock E, et al. Magnesium and the inflammatory response: potential physiopathological implications [J]. Arch Biochem Biophys, 2007, 458 (1): 48-56.
16. Ludwig M, von Petzinger-Kruthoff A, von Buquoy M, et al. Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint [J]. Ultraschall Med, 2003, 24 (3): 162-74.
17. Chiuve SE, Korngold EC, Januzzi JJ, et al. Plasma and dietary magnesium and risk of sudden cardiac death in women [J]. Am J Clin Nutr, 2011, 93 (2): 253-260.
18. Verduyn SC, Vos MA, van der Zande J, et al. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium [J]. Cardiovasc Res, 1997, 34 (3): 453-463.
19. Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension [J]. Am J Physiol Heart Circ Physiol, 2008, 294 (3): H1103-1118.
20. Dong JY, Xun P, He K, et al. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort students [J]. Diabetes Care, 2011, 34 (9): 2116-2122.
21. Srinivasan AR, Niranjan G, Kuzhandai Velu V, et al. Status of serum magnesium in type 2 diabetes mellitus with particular reference to serum triacylglycerol levels [J]. Diabetes Metab Syndr, 2012, 6 (4): 187-189.
22. Chiuve SE, Sun Q, Curhan GC, et al. Dietary and plasma magnesium and risk of coronary heart disease among women [J]. J Am Heart Assoc, 2013, 2 (2): e000114. [2014-06-20]. http://jaha.ahajournals.org/content/2/2/e000114.long.